BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21417873)

  • 1. Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
    Tapısız A
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):339-46. PubMed ID: 21417873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin therapy in immunocompromised children and neonates.
    Somer A; Törün SH; Salman N
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):347-55. PubMed ID: 21417874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anidulafungin: a novel echinocandin for candida infections.
    de la Torre P; Meyer DK; Reboli AC
    Future Microbiol; 2008 Dec; 3(6):593-601. PubMed ID: 19072176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and antifungal properties of anidulafungin, a new echinocandin.
    Estes KE; Penzak SR; Calis KA; Walsh TJ
    Pharmacotherapy; 2009 Jan; 29(1):17-30. PubMed ID: 19113794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anidulafungin: when and how? The clinician's view.
    George J; Reboli AC
    Mycoses; 2012 Jan; 55(1):36-44. PubMed ID: 21668526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anidulafungin--state of affairs from a clinical perspective.
    Vehreschild JJ; Kümmerle T; Karthaus M; Cornely OA
    Mycoses; 2007; 50 Suppl 1():38-43. PubMed ID: 17394608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R; Khachikian D; Reboli AC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinocandins: addressing outstanding questions surrounding treatment of invasive fungal infections.
    Holt SL; Drew RH
    Am J Health Syst Pharm; 2011 Jul; 68(13):1207-20. PubMed ID: 21690427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anidulafungin for the treatment of invasive candidiasis.
    Mayr A; Aigner M; Lass-Flörl C
    Clin Microbiol Infect; 2011 Mar; 17 Suppl 1():1-12. PubMed ID: 21251147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of invasive candidiasis with echinocandins.
    Glöckner A; Steinbach A; Vehreschild JJ; Cornely OA
    Mycoses; 2009 Nov; 52(6):476-86. PubMed ID: 19076282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Potential of anidulafungin in hematological patients].
    Vázquez López L; Ruiz Camps I
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():44-50. PubMed ID: 19572434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anidulafungin: a new echinocandin with a novel profile.
    Vazquez JA
    Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis Infections: a meta-analysis.
    Kale-Pradhan PB; Morgan G; Wilhelm SM; Johnson LB
    Pharmacotherapy; 2010 Dec; 30(12):1207-13. PubMed ID: 21114387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.
    Kuti EL; Kuti JL
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1287-300. PubMed ID: 20822479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.